Exact Sciences Corporation raised revenue guidance for the year 2022. For the year, company anticipates revenue of $1,985 million to $2,032 million during 2022. Revenue guidance has been raised and narrowed toward the high end of the previously expected range of $1,975 million to $2,027 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
59.54 USD | +1.27% | -2.48% | -19.64% |
Apr. 17 | Exact Sciences Corporation announced that it has received $266.75 million in funding | CI |
Apr. 15 | Sector Update: Health Care Stocks Advance Premarket Monday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.64% | 10.67B | |
+40.96% | 3.22B | |
-35.36% | 2.09B | |
-18.92% | 2.04B | |
-28.95% | 1.46B | |
+19.16% | 1B | |
-4.37% | 734M | |
-35.83% | 391M | |
-45.92% | 379M | |
+16.90% | 343M |
- Stock Market
- Equities
- EXAS Stock
- News Exact Sciences Corporation
- Exact Sciences Corporation Raises Revenue Guidance for the Year 2022